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A B S T R A C T
Oxidative stress is a pathogenic feature in vitreoretinal disease. However, the ability of the inner retina to
manage metabolic waste and oxidative stress is unknown. Proteomic analysis of antioxidants in the human
vitreous, the extracellular matrix opposing the inner retina, identified superoxide dismutase-3 (SOD3) that lo-
calized to a unique matrix structure in the vitreous base and cortex. To determine the role of SOD3, Sod3-/- mice
underwent histological and clinical phenotyping. Although the eyes were structurally normal, at the vitreor-
etinal interface Sod3-/- mice demonstrated higher levels of 3-nitrotyrosine, a key marker of oxidative stress.
Pattern electroretinography also showed physiological signaling abnormalities within the inner retina. Vitreous
biopsies and epiretinal membranes collected from patients with diabetic vitreoretinopathy (DVR) and a mouse
model of DVR showed significantly higher levels of nitrates and/or 3-nitrotyrosine oxidative stress biomarkers
suggestive of SOD3 dysfunction. This study analyzes the molecular pathways that regulate oxidative stress in
human vitreous substructures. The absence or dysregulation of the SOD3 antioxidant at the vitreous base and
cortex results in increased oxidative stress and tissue damage to the inner retina, which may underlie DVR
pathogenesis and other vitreoretinal diseases.
1. Introduction
Reactive oxygen species (ROS) are a consequence of aerobic re-
spiration and substrate oxidation within the cell. At physiological le-
vels, ROS are required for many cellular functions, including immune
function and signal transduction [1]. However, excess production or
inadequate removal results in oxidative stress through high levels of
ROS which can react with macromolecules. Oxidative stress has been
implicated in a wide variety of human diseases such as atherosclerosis,
hypertension, heart failure, and diabetes [2].
The eye has particularly high levels of oxidative stress for several
reasons. First, the retina is the most metabolically active tissue in the
human body [3]. Second, the metabolic exchange between the vitreous
and systemic circulation is slow [4], which means that the retina must
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cope with a large amount of oxidative stress as a result of the high
metabolic activity, yet it has a relatively inefficient exchange process.
The retinal pigment epithelium (RPE) and choroid (a large vascular
plexus) line the outer retina to remove metabolic waste, but no similar
cellular or vascular system exists for the inner retina, since light must
reach the retina without interference. Instead, the inner retina is op-
posed by the vitreous, an optically transparent, extracellular matrix
(ECM). How the inner retina manages metabolic waste is not known,
but it may be especially vulnerable in metabolic disorders such as
diabetes, where intracellular mechanisms are dysfunctional.
Indeed, elevation of intraocular ROS in the vitreous is implicated in
the pathogenesis of diabetic vitreoretinopathy (DVR), but the molecular
mechanisms are not known. Since oxidative stress is closely linked to
the intraocular neovascularization [5,6], inflammation [7], fibrosis,
and tractional retinal detachment that characterize DVR, we sought to
study the molecular mechanisms of oxidative stress regulation in the
vitreous. SODs are a family of enzymes that catalyze the dismutation of
superoxide, converting it into hydrogen peroxide and dioxygen. There
are several isoforms of superoxide dismutase: SOD1 (cytosolic), SOD2
(mitochondrial), and SOD3 (extracellular) [8]. Mutations within both
SOD1 and SOD2 are implicated in human disease, such as amyotrophic
lateral sclerosis (ALS) and ischemic heart disease, respectively [9–12].
SOD3 is a secretory, homotetrameric, Cu/Zn-containing SOD that is
found primarily in the ECM and on cell surfaces. SOD3 binds heparan
sulfate proteoglycans (HSPGs) and collagen which function to anchor it
to the ECM. It is hypothesized that these ECM proteins keep SOD3 lo-
cally sequestered until needed, and it has been previously shown that
the single nucleotide polymorphism (SNP) R213G in SOD3 alters its
biodistribution to be in favor of the unbound form [13,14]. Regions of
the eye that are composed of higher concentrations of collagen and
HSPGs include the vitreous base and the posterior hyaloid. In our study,
we found that SOD3 is differentially localized to vitreous substructures
through specific proteoglycan interactions to prevent oxidative damage
to the adjacent neural retina. Our study shows that dysregulation of
SOD3 interactions and activity at the vitreous base may be critical in
the pathophysiology of DVR and other oxidative stress-related vitreor-
etinopathies.
2. Results
2.1. Oxidative stress proteins in the human vitreous
To identify proteins that regulate oxidative stress in the retina and
vitreous, we interrogated human proteomics datasets [15] using gene
ontology (GO) analysis [16]. There were 75 proteins in the human re-
tina and vitreous categorized as oxidoreductases (Fig. 1A). Of these,
there were 6 proteins identified in the retina with known antioxidant
activity (GO: 0016209) and 9 in the vitreous. Three antioxidant pro-
teins were unique to the vitreous: superoxide dismutase-3 (SOD3), eo-
sinophil peroxidase (EPX), and arachidonate 5-lipoxygenase-activating
protein (ALOX5AP; Fig. 1B) [15]. A network of these interacting pro-
teins was generated (Fig. 1C) [17,18]. Since the vitreous is an ECM and
SOD3 was absent from the retina, we hypothesized that extracellular
SOD3 may regulate the oxidative stress response in the vitreous. Net-
work analysis of vitreous proteins identified 23 SOD3 interactors, fur-
ther suggesting that SOD3 may play a role in regulating the oxidative
stress response in the vitreous (Fig. 1D).
2.2. SOD3 is concentrated within the vitreous base in a unique and highly
organized pattern
To determine if SOD3 was differentially active in the vitreous sub-
structures, the vitreous base, core, and cortex were dissected and ana-
lyzed with a xanthine oxidase (XO) based SOD activity assay (Fig. 2A).
XO is an enzyme that generates superoxide, and the percent SOD ac-
tivity of each tissue sample corresponds to the amount of superoxide
dismutated. This assay recognizes zinc-bound forms of SOD (SOD1 and
SOD3) but not the manganese bound form (SOD2). The level of SOD
activity was variable between human eye samples, but activity of SOD
was found to be higher within the vitreous base, suggesting that SOD3
may be sequestered at the vitreous base to regulate oxidative stress
within the eye (Fig. 2A). To verify SOD3-specific expression in the
vitreous substructures of the human eye, and more closely examine the
vitreous ECM substructures, we performed immunohistochemistry
(IHC) on sagittal sections of human eye vitreous [15]. We found that
SOD3 expression was concentrated in the vitreous base (overlying the
ciliary body; Fig. S1A-C; Fig. 2B) and vitreous cortex (at the vitreor-
etinal interface; Fig. S1D-F; Fig. 2C). At higher magnification, SOD3
expression was organized in a looped pattern, reminiscent of the highly
organized structures of the ECM in the vitreous (Fig. S1C, F; Fig. 2B, C).
2.3. SOD3 interacts with extracellular matrix proteins in the vitreous
The distinct looped pattern of SOD3 in the vitreous base and cortex
suggested that it was binding specific ECM proteins. In order to de-
termine if any of the vitreous collagens or proteoglycans co-localize
with the SOD3 expression pattern, several of the ECM proteins that
were identified in our vitreous proteomics profiling screen (e.g. decorin
and aggrecan; Fig. 1D) were blotted onto PVDF membranes (Fig. 2D).
Additional known binding partners for SOD3, such as heparan sulfate
proteoglycans (HSPGs) and syndecans 1 and 2 (Syn1 and Syn2), were
also blotted on the PVDF membrane. Membranes were incubated with
SOD3 protein (left blot, depicted in left cartoon panel), and SOD3 was
shown to bind strongly to heparin in the vitreous (Fig. 2D; left blot).
Since the c-terminus of SOD3 contains amino acids implicated in in-
teractions with other proteins, we tested recombinant SOD3 missing the
heparin-binding domain (HBD; ECSODΔHBD; middle panel) or mutated
with R213G in the HBD (right panel) for their ability to interact with
purified vitreous proteins and proteoglycans. In non-ocular tissues, both
of these mutants fail to interact with their glycosaminoglycan target. In
our assay, both the HBD and R213G mutant SOD3 proteins removed the
binding signal to heparin in the dot blot assay (Fig. 2D; middle and right
blots).
Since both ECM proteins found in our vitreous proteomics screen
(decorin and aggrecan) did not seem to bind SOD3 at detectable levels,
we confirmed this potential lack of binding for decorin using im-
munohistochemistry (IHC). We tested SOD3 activity and co-localization
in the vitreous base for both heparin (a known binding partner with
strong binding on the dot blot assay) and decorin. SOD3 activity was
completely blocked in the presence of heparin (data not shown). Both
SOD3 (green; open circle) and decorin (red; arrow) localized to the
same organized looped pattern within the vitreous base, but no co-lo-
calization of SOD3 and decorin was detectable with IHC (Fig. 2E).
There may be limited SOD3 co-localization with decorin in the vitreous
base that we were unable to detect, but this result suggests that SOD3
interaction with decorin is not the primary interaction responsible for
SOD3 sequestration to the vitreous base, and SOD3 binding to heparin
is an interaction that occurs within the vitreous base of the human eye.
Similar results were found at the vitreous cortex (data not shown).
2.4. Sod3 functions within the mouse vitreous
We have previously published the identification of the vitreous
substructures in mice based on anatomical location [19]. It has not been
possible to dissect the specific substructures of the mouse vitreous, but
IHC of the whole mouse vitreous showed the presence of Sod3 (green;
Fig. 3A) concentrated at the vitreous base (labeled vb) and vitreous
cortex (labeled vc), similar to the human vitreous SOD3 sequestration.
Currently, no data has been published to analyze the Sod3 knockout
phenotype within the eye. Histologically, Sod3-/- mice displayed a
normal retina, with no signs of cataract or membranes (data not
shown). As expected, the Sod3-/- mice showed no Sod activity in
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comparison to their wild-type controls (Fig. 3B).
2.5. Loss of Sod3 leads to increased oxidative stress at the vitreoretinal
interface
Since SOD3 is an important regulator of oxidative stress, potential
oxidative stress markers related to the loss of Sod3 function were stu-
died within the mouse vitreous and inner retina. Nitrates and 3-ni-
trotyrosine are byproducts of oxidative stress, and elevated levels of
nitrate or 3-nitrotyrosine indicates increased oxidative stress. Sievers
nitrate analysis showed no change in nitrate levels between Sod3-/-mice
and control mice (Fig. 3C). However, 3-nitrotryosine was elevated in
both the vitreous and the retinal ganglion cell (RGC) layer of the Sod3-/-
mice in comparison to controls (Fig. 3D). 3-nitrotyrosine expression
was comparable between both the Sod3-/- mice and controls in the outer
retinal layers, suggesting that Sod3 plays a key role in oxidative stress
regulation at the vitreoretinal interface.
2.6. Loss of Sod3 causes inner retinal dysfunction
Since the ocular phenotype of Sod3-/- mice has not been character-
ized, we analyzed these mice for clinical pathologies that may be found
in human patients with ocular disorders related to increased oxidative
stress. Optical coherence tomography (OCT) was used to determine
whether there was a loss of the neural retinal layers. Five recordings
were taken of the neural retina thickness at the same scan line of the
eye, at both the scleral (OCT-S) and optic nerve head regions (OCT-
ONH). No significant changes were found in the thickness of the neural
retina between Sod3-/- mice and their controls (Fig. 4A). Intra-ocular
pressure was then recorded from male mice at 4 months of age, with 4
recordings per eye, with no significant difference (p= 0.4; Fig. 4B). To
further examine the RGCs, where increased 3-nitrotyrosine was found
at the vitreoretinal interface (Fig. 3D), we performed pattern
electroretinograms (PERGs), which reflect inner retinal electro-
physiology, on the Sod3 knockout mice and their controls (Fig. 4C).
Representative traces displayed a loss of function from the RGCs in the
Sod3-/- mice (blue trace) compared to controls (black trace; Fig. 4C; top
panel). Quantification of the cohort of mice analyzed showed a loss of
RGC function in the Sod3-/-mice based on a significantly reduced P50 to
N95 PERG amplitude (p= 0.0054; Fig. 4C; middle). N95 latency times
were trending lower in the Sod3-/- mice compared to controls; however,
these were not significantly changed between groups (p=0.22;
Fig. 4C; lower). Full-field ERGs, which reflect whole retinal electro-
physiology, were normal (data not shown), indicating the physiological
defect localized to the inner retina and not the outer retina. Thus, the
loss of Sod3 leads to a significant decline in PERG inner retinal re-
sponses, a clinical phenotype seen in human patients with diabetic vi-
treoretinopathy (DVR) and other vitreoretinopathies. This finding was
also consistent with the increased oxidative stress observed at the inner
retina of Sod3-/- mice.
We then treated the Sod3-/- mice with Tempol (4-hydroxy-2,2,6,6-
tetramethylpiperidine-N-oxyl). Tempol is a redox-cycling nitroxide
water-soluble SOD mimetic agent that acts as a potent antioxidant by
reducing oxidative stress from the metabolism of a large variety of
cellular reactive oxygen and nitrogen species [20–23]. To provide
Tempol for the long-term duration of the experiment, Sod3-/- mice and
respective controls were placed on Tempol via their drinking water. To
offset the taste of Tempol and ensure that the mice drink their water for
a steady dosage, sucrose was added into the drinking water. An addi-
tional experimental group for both wild-type and Sod3-/- mice were
placed on sucrose-only drinking water during the duration of the ex-
periment. Representative traces for each of the four experimental
groups are shown in Fig. 5A, as compared to representative control
traces shown in Fig. 4C. We then quantified the PERG responses for all
groups, both controls and experimental mice (Fig. 5B). Unexpectedly,
the addition of sucrose alone to the drinking water caused for a
Fig. 1. Interrogation of human retina and
vitreous proteomes reveals superoxide dis-
mutase 3 (SOD3) to be present in the vitreous.
(A) Gene ontology (GO) analysis was per-
formed on our previously-published human
retina and vitreous proteomic datasets.
Proteins categorized as oxidoreductases were
identified in both tissues. (B) Proteins con-
taining ‘antioxidant activity’ (GO:0016209)
were identified in both tissues. Three of these
proteins were unique to the vitreous: super-
oxide dismutase (SOD3), eosinophil peroxidase
(EPX), and arachidonate 5-lipoxygenase-acti-
vating protein (ALOX5AP). (C) A network of
these antioxidant proteins was generated using
STRING and visualized using Cytoscape.
Circles represent proteins (nodes) and lines
represent known interactions (edges). (D)
Network analysis of the 5211 total proteins in
the human vitreous identified 23 SOD3 inter-
actors. ATP2A1, Sarcoplasmic/Endoplasmic
Reticulum Calcium ATPase 1; ATP2A3,
Sarcoplasmic/Endoplasmic Reticulum Calcium
ATPase 3; APOE, Apolipoprotein E; CAT,
Catalase; CP, Ceruloplasmin; DECR1, Decorin;
GAP, GTPase Activating Protein; GPX1,
Glutathione Peroxidase 1; GPX3, Glutathione
Peroxidase 3; GPX4, Glutathione Peroxidase 4;
GSR, Glutathione Reductase, Mitochondrial;
HSPA9, Stress-70 Protein, Mitochondrial;
PRDX1–6, Peroxiredoxin 1–6; SOD1,
Superoxide Dismutase 1; SOD2, Superoxide
Dismutase 2; TKT, Transketolase; TXN,
Thioredoxin.
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significant increase in inner retinal function in the Sod3-/-mice (orange)
compared to untreated Sod3-/- mice (p=0.0141; blue), but not in the
wild-type mice (p=0.3698; black and gray; Fig. 5B). However, the
addition of Tempol to the drinking water enhanced the inner retinal
function in both the wild-type (p= 0.0353; green; Fig. 5) and Sod3-/-
mice (p= 0.0151; red; Fig. 5). However, there was no significant
Fig. 2. SOD3 is concentrated in the human vitreous base and cortex in a highly organized, looped pattern. (A) Specific vitreous substructures (base, core and cortex)
were dissected and SOD activity (from both SOD1 and SOD3) was determined using a xanthine oxidase assay. Error bars = SEM. N=3 replicates per sample and 4
vitreous samples per substructure. (B) IHC for SOD3 (green) shows a unique looped pattern located within the vitreous base. Collagen IV (red) stains the basal lamina.
Scale bar, 12 µm. (C) IHC for SOD3 (green) shows a unique looped pattern located within the vitreous cortex, by the vitreoretinal interface. Scale bar, 10 µm. (D)
Human SOD3 (SOD3; left cartoon panel), human recombinant SOD3 with a deletion of the heparin/collagen binding domain (SOD3ΔHBD; middle cartoon panel),
and human recombinant SOD3 with the R213G mutation in the heparin/collagen binding domain (SOD3 R213G; right cartoon panel) were incubated on a PVDF
membrane in a dot blot assay against glycosaminoglycans (GAGs) and extracellular matrix (ECM) proteins found in the vitreous (top blots). Negative control blots
without SOD3 incubation are shown below. rSOD1, recombinant superoxide dismutase 1; rhSOD3, recombinant human superoxide dismutase 3; CMV-SOD3, su-
peroxide dismutase 3 purified after over-expression with the cytomegalovirus ubiquitous promoter in human cells; SOD3, purified superoxide dismutase 3; Syn1,
syndecan 1;Syn2, syndecan 2; ACAN, aggrecan. (E) Immunostaining confirmed that decorin (red; arrow) was present in the looped pattern in the human vitreous base
but did not co-localize with SOD3 (green; white circle). Cell nuclei were stained by DAPI (blue). Scale bar, 10 µm.
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difference between mice treated with sucrose alone compared to mice
treated with Tempol and sucrose (p=0.9566 for wild-type mice and
p=0.9961 for Sod3-/- mice). Overall, both sucrose and sucrose with
Tempol delivered via the drinking water was able to offset the loss of
inner retina function detectable by PERG in mice lacking Sod3.
2.7. Human diabetic vitreoretinopathy
Oxidative stress is a key feature of human DVR [24]. Compared to a
normal human fundus (Fig. 6A), patients with early stages of DVR ex-
hibit a loss of inner retinal function, visible using PERG (Fig. 6B). The
Fig. 3. Sod3 is detectable in the vitreous base and cortex
of the mouse eye and loss of Sod3 results in increased
oxidative stress. (A) IHC confirmed the presence of Sod3
(green) within the mouse vitreous base (red arrow) and
concentrated at the vitreous cortex (white arrow). Scale
bar = 20 µm. VB, vitreous base; VC, vitreous cortex. (B)
Sod3 knockout mice had no Sod3 activity compared to
wild-type controls, based on a xanthine oxidase assay
(p=0.0045). N=3 replicates per group. (C) Nitrate le-
vels in the mouse vitreous remained unchanged between
wild-type and Sod3 knockout mice. N= 5 replicates per
mouse, 2 mice analyzed per group. Error bars represent
the standard error of the mean. (D-E) IHC showed that 3-
nitrotyrosine was increased within the Sod3 knockout
mouse vitreous (red arrow) compared to a wild-type
mouse. (F-G) 3-Nitrotyrosine was also increased within the
retinal ganglion cell layer of the neural retina and at the
vitreoretinal interface (purple arrows).
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PERG responses in DVR patients without late clinical pathology (no
epiretinal membranes, cataracts, or other severe clinical presentations)
displayed diminished inner retina function despite normal outer retina
(photoreceptor) function (red) compared to a control patient (black;
Fig. 6B). At later stages of DVR, despite control of retinal neovascu-
larization following laser photocoagulation of the peripheral retina,
patients develop progressive fibrosis along the vitreoretinal interface
(Fig. 6C). The normally clear vitreous cortex becomes opaque due to
fibrotic membranes exerting traction on the retinal surface, as can be
confirmed by infrared imaging (Fig. 6D). IHC of the vitreoretinal
membrane from a DVR patient showed vitreoretinal adhesion, trac-
tional retinal detachment, and an epiretinal membrane (Fig. 6E). To-
gether, these indicate a dysfunction at the vitreoretinal interface
leading to visual impairment in patients presenting with DVR. Disrup-
tion of oxidative stress management mechanisms at this interface could
account in part for defects in the inner retina, suggesting a role for
SOD3 in DVR.
2.8. SOD3 activity in diabetic vitreoretinopathy
IHC of epiretinal membranes from a human DVR patient showed
SOD3 expression (green), as well as decorin (red; Fig. 7A), but they
were not co-localized. Since SOD3 was present in the fibrous epiretinal
membranes near the inner retina of DVR patients, it's possible that
SOD3 dysregulation at the vitreous base may lead to changes in oxi-
dative stress at the vitreoretinal interface. We measured changes in
oxidative stress in human DVR patients and found that reducible nitrate
concentrations were significantly increased (p= 0.036), and on
average there was more than a two-fold increase in DVR vitreous
samples compared to control samples (Fig. 7B). We have previously
published a mouse model for proliferative diabetic retinopathy (PDR),
where the von Hippel Lindau tumor suppressor protein (VHL) was
knocked out within the photoreceptor cells [25]. IHC for 3-nitrotyr-
osine in the vitreous of this mouse model for PDR showed a severe
increase in oxidative stress in the vitreous compared to both wild-type
and Sod3 knockout mice (Fig. 7C). Elevation of intraocular reactive
oxygen species (ROS) in the vitreous is implicated in the pathogenesis
of DVR, as well as other vitreoretinopathies, but the molecular me-
chanisms are not known. We have shown that SOD3 is differentially
localized to the vitreous base through heparin interactions and acts to
prevent oxidative damage at the vitreoretinal interface. Therefore,
dysregulation of SOD3 may be critical in the pathophysiology of DVR.
3. Discussion
The goal of this investigation was to better understand the role the
vitreous might play in the regulation of oxidative stress that affects the
neural retina. We sought differentially expressed molecules from our
Fig. 4. Loss of Sod3 leads to inner retinal dysfunction. (A)
Thickness of the neural retina was determined using op-
tical coherence tomography (OCT) at both the scleral
(OCT-S) and optic nerve head (OCT-ONH) regions of the
retina. All recordings were taken from the same scan line
(19/32) and 5 recordings per eye were used for analysis.
N=6 Sod3+/+ mice and 7 Sod3-/- mice. (B) Intraocular
pressure was found to trend slightly higher in the Sod3
knockout mice compared to wild-type controls, although
not significantly altered (p=0.4). All mice examined
were males at 4 months of age, with 4 recordings per eye.
N=6 mice for Sod3+/+ and 4 mice for Sod3-/-. (C)
Representative traces from the pattern electroretinogram
(pERG) showed a decline in visual response in the Sod3-/-
mouse (blue) compared to a Sod3+/+ control mouse
(black; top). Quantification of the pERG amplitude from
the peak of P50 to trough of N95 showed a significant
decrease in the Sod3 knockout mice compared to controls
(middle; p=0.0054), while the N95 latency was lower
but not significant between the two groups (bottom;
p= 0.22). N=7 mice per group. Error bars = standard
deviation. *, p < 0.01.
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proteomics data and studied their role in vitreoretinal disease. This
study utilized a novel method to dissect human vitreous from the
cortex, core, and base. In fresh human donor eyes, IHC of superoxide
dismutase-3 (SOD3) revealed a remarkable pattern of expression: SOD3
showed a punctate pattern following a “looping” found at the vitreous
base and cortex (Fig. 2B, C). This “looping pattern” has not been de-
scribed previously, and its composition is not known.
In non-ocular tissues, SOD3 is sequestered to heparin and collagen I
[26,27]. Binding to these extracellular substances represents a way for
SOD3 to be concentrated where its activity is required. The eye is an
area of high oxidative stress due to UV radiation, high metabolic ac-
tivity, and high oxygen tension [28], and it would be likely for SOD3 to
play a key role in the regulation of oxidative stress within the eye. Since
sulfate proteoglycans and several collagens are primary constituents of
the human vitreous base and cortex, these are likely interaction can-
didates for SOD3 within the vitreous. We demonstrated that SOD3
binds with heparin in the vitreous base, but not the other tested pro-
teoglycans from the vitreous (i.e. decorin and aggrecan). Sequestration
of SOD3 in areas of oxidative damage is crucial to prevent the super-
oxide radical from reacting promiscuously with neighboring structures.
The pattern of localization for SOD3 suggests the presence of a specific
interaction(s) to keep SOD3 adjacent to the inner retina, ciliary body,
and lens where it can protect these tissues from oxidative damage. This
may be particularly important to the inner retina, the site of the neu-
ronal cell signaling complexes, as well as the ciliary body, which pro-
duces the aqueous humor that provides oxygenation and nutrients to
the lens and cornea.
Our study confirmed Sod3 to be present in the vitreous base and
cortex of mice, similar to humans. Sod3 knockout mice were examined
for potential ocular phenotypes, as they had not been previously
characterized for eye abnormalities. Our results demonstrate that ni-
trates were variable but not altered between Sod3-/- mice and control
mice, but that 3-nitrotyrosine was present in both the vitreous and the
retinal ganglion cells (RGCs), with the highest levels at the vitreoretinal
interface. Along with increased oxidative stress at the vitreoretinal in-
terface, Sod3-/- mice had a loss of PERG function in comparison with
controls, which was rescued following treatment with sucrose and an
antioxidant, suggesting that the loss of Sod3 in the vitreous causes
changes in the oxidative stress response of the inner neural retina that
leads to vision defects.
The rescue effect visible after sucrose delivery is likely due to the
high metabolic activity of the photoreceptor cells. It has been shown in
mice that rod photoreceptor cells rely on glycolysis for their outer
segment biogenesis [29]. Additionally, previous studies have shown
that glucose is able to reduce ROS in cultured rat retinal cells by acting
on both the glycolytic and pentose phosphate pathways [30], and that
enhancing glycolysis in the photoreceptor cells and releasing retained
glucose from the RPE to starving photoreceptors provide short-term
rescue effects to models of retinitis pigmentosa [31]. Even a high car-
bohydrate diet, raising blood glucose levels, improved retinal function
in disease systems, but was unable to restore the synaptic contacts at
the retinal ganglion cell layer [32]. SOD3 has been shown to increase
Fig. 5. Sod3 inner retinal dysfunction is rescued after
treatment with sucrose and a potent antioxidant. (A)
Representative traces from the experimental PERGs for
mice with sucrose delivery via the drinking water (Sod3-/-
mouse, orange; wild-type mouse, gray) and with the ad-
dition of tempol, a potent antioxidant, to the drinking
water (Sod3-/- mouse, red; wild-type mouse, green). PERG
amplitude is marked by an arrow. (B) Quantification of the
PERG amplitudes showed a significant restoration in am-
plitude in the Sod3 knockout mice after both sucrose
(p=0.0141; orange) and tempol delivery (p= 0.0151;
red) in comparison to untreated Sod3 knockout mice
(blue). There was also a significant restoration of PERG
amplitude in wild-type mice treated with Tempol and su-
crose (green) in comparison to untreated wild-type mice
(p=0.0353; black). There was no significant difference
between untreated wild-type mice (black) and wild-type
mice with sucrose treatment (p= 0.3698; gray). There
was also no significant difference between mice treated
with sucrose alone compared to mice treated with Tempol
and sucrose (p= 0.9566 for wild-type mice and
p= 0.9961 for Sod3-/- mice). N≥ 3 mice per group. Error
bars = standard deviation. *, p < 0.05.
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glucose metabolism [33] as an additional mechanism of reducing ROS
levels. We have recently observed, using gene ontology, that anti-
oxidant activity was highly expressed in the juxta-macular and per-
ipheral retina, and that metabolic pathways were differentially ex-
pressed in various retinal regions (foveomacular, juxta-macular and
peripheral retinal regions) in the human eye [34]. Therefore, the ad-
dition of sucrose and its effect on metabolic regulation in the inner
retina may be masking the increased oxidative stress caused by a loss of
Sod3. In human patients, it may be possible to alleviate retinal disorders
related to SOD3 dysregulation by direct injection of either glucose or a
Tempol compound into the intravitreal space of the eye.
Mouse models of diabetes have implicated a role of both Sod1 and
Sod3 in increased levels of superoxide anions and vascular tissue da-
mage, phenotypes also found in diabetic humans. In KK/Ta-Akita dia-
betic mice, for example, levels of Sod1 and Sod3 are below normal,
corresponding to elevated levels of superoxide production and de-
creased glomeruli filtering function [35]. Increased infiltration of in-
flammatory cells as well as increased fibrosis have been demonstrated
in lung and heart tissues of the Sod3-/- mouse [36,37]. In our murine
model of proliferative diabetic retinopathy [25], we found increased 3-
nitrotyrosine within the vitreous, indicative of high oxidative stress.
The Sod3-/- mice show that the absence or dysregulation of Sod3 results
in increased oxidative stress and tissue damage, a phenotype not pre-
viously studied with this murine model system, and this phenotype
shows clinical similarities to that seen in DVR patients and patients of
other vitreoretinopathies.
Additionally, many studies have linked increased oxidative stress to
development of diabetes related complications, including DVR [38].
Elevated glucose levels cause the release of ROS which is considered to
be a causal link between the metabolic abnormalities in diabetic
Fig. 6. Clinical pathology of human diabetic vitreoretinopathy. (A) Normal human fundus image. (B) pERG traces displaying a reduction in visual response in human
patients with early-stage diabetic vitreoretinopathy (DVR; red) compared to normal human patients (black). (C) Fundus image of a patient with later-stage DVR. (D)
Infrared image from a patient with DVR displaying inflammation and hemorrhaging within the eye. (E) IHC of the posterior hyaloid and vitreoretinal membrane from
a patient with DVR showing the presence of an epiretinal membrane, vitreoretinal adhesion and tractional retinal detachment.
K.J. Wert et al. Free Radical Biology and Medicine 124 (2018) 408–419
415
patients and the development of complications. We examined SOD3 in
human DVR patients using biopsies of the vitreous and epiretinal
membranes. We found that SOD3 is present in epiretinal membranes
from the DVR patient vitreous samples. Nitrates were also significantly
increased in DVR patients compared to controls, providing further
evidence for increased oxidative stress in the eyes of diabetic subjects.
Our results suggest that patients with DVR have increased levels of
oxidative stress at the vitreoretinal interface, possibly due to the dys-
regulation of SOD3 in the vitreous base.
Based on our findings, SOD3 compartmentalizes to the vitreous base
and cortex, regulates oxidative stress at the vitreoretinal interface, and
influences electrophysiology at the inner neural retina. Understanding
how SOD3 is localized to specific vitreous substructures may provide
insight into the molecular mechanisms regulating intraocular oxidative
stress in DVR. Furthermore, since intraocular oxidative stress is asso-
ciated with the pathogenesis of age-related macular degeneration [39]
and glaucoma [40], these experiments have implications for other
blinding eye diseases. Overall, regulation of SOD3 at the vitreous base
and cortex may represent a future therapeutic target for vitreoretinal
diseases. Future studies are needed to further elucidate the binding
activity of SOD3 at the vitreoretinal interface and the mechanism by
which it protects the inner retina.
4. Materials and methods
The study protocol was approved by the Institutional Review Board
for Human Subjects Research (IRB) at the University of Iowa and
Stanford University, was HIPAA compliant, and adhered to the tenets of
the Declaration of Helsinki. All subjects underwent informed consent
for study participation. All experiments were performed in accordance
with the ARVO Statement for the Use of Animals in Ophthalmic and
Visual Research and were all approved by the Animal Care and Use
Committee at the University of Iowa and Stanford University.
4.1. Human vitreous biopsies
A 23 gauge vitreous cutter (Alcon Laboratories Inc, Fort Worth, TX)
was inserted and the cutter was activated for 30 s. A 250−500mL
vitreous was then manually aspirated into a second syringe. Following
sampling the vitreous, a core vitrectomy proceeded as normal. Vitreous
samples were immediately centrifuged in the operating room at
15,000 g for 5min at room temperature to remove particulate matter.
All samples were then stored at − 80 °C.
4.2. Human vitreous dissection
Human donor eyes were dissected within four hours or less from
death. The cornea was cut circumferentially around the limbus and
removed. The iris was then removed by cutting circumferentially at
near the ciliary body using curved Westcott scissors. Next, the vitreous
core was aspirated using a 23 gauge needle until completely removed.
Aspirating the vitreous core allows the anterior hyaloid to be easily
visualized as a transparent ring within the anterior opening where the
cornea was removed. This tissue was very carefully grasped using 0.12
colibri forceps and pulled away from the ciliary body. Small vannas
scissors were used to cut the anterior hyaloid away from the ciliary
body and sclera. After all of the hyaloid was collected, the eye cup was
flowered into four quadrants and the ciliary body was removed from
each quadrant. Using 0.22mm forceps, the vitreous base was pulled up
from the region spanning the pars plana, ora serrata, and 3mm pos-
terior to the ora serrata, while Westcott scissors were used to cut the
vitreous base away from the other tissues. Vitreous base was collected
from all four quadrants and then the ora serrata, including 3mm pos-
terior, was cut and removed from the quadrants as well. The posterior
cortex was lifted away from the retina using 0.12 colibri forceps and cut
using Westcott scissors. All samples were put into a 1.5 mL tube and
frozen in liquid nitrogen immediately after collection.
Fig. 7. A role for SOD3 in the regulation of
oxidative stress in diabetic vitreoretinopathy.
(A) IHC in an epiretinal membrane from a
human with DVR showed SOD3 (green) and
decorin (red), but no co-localization. Cell nu-
clei are stained with DAPI (blue). (B) Nitrates
were found to be significantly increased in
human DVR patients compared to controls
(p=0.036). *, p < 0.05. Error bars = stan-
dard deviation. N= 9 controls, 10 DVR pa-
tients. (C) IHC showed increased levels of 3-
nitrotyrosine in the Sod3 knockout mice
(middle), and a severe increase in 3-nitrotyr-
osine in a mouse model for proliferative dia-
betic retinopathy (right), compared to wild-
type controls (left).
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4.3. Human posterior hyaloid excision
Surgical intervention with vitrectomy, posterior hyaloid dissection
and epiretinal membrane peeling was performed on a 66-year-old male
with type 2 diabetes mellitus controlled on oral hypoglycemic agents
and a history of bilateral proliferative diabetic retinopathy previously
treated with extensive panretinal photocoagulation. He had clinically
significant macular edema OS and vitreomacular traction with a vision
of 20/50 OS, after undergoing extensive focal laser treatment. The
patient had diffuse leakage from areas of chronic neovascularization
along the inferotemporal arcade, which corresponded to areas of sig-
nificant vitreoretinal traction as noted on OCT. Intravitreal bev-
icizumab was provided in an attempt to reduce the edema, which was
ineffective.
4.4. Imaging
Fundus SW-AF and SD-OCT images were obtained in all patients
after dilation using Spectralis HRA+OCT device (Heidelberg
Engineering, Heidelberg, Germany). SW-AF images were acquired using
a 30-degree field of view with 1536×1536 pixel resolution. SW-AF
imaging utilized a 521 nm barrier filter and 486 nm wavelength sti-
mulus. The external horizontal and vertical ring diameter of SW-AF
imaging was measured manually using Spectralis software (Heidelberg
Eye explorer, software version 1.9.10, Heidelberg Engineering). SD-
OCT was obtained with an 870 nm light source and automatic real-time
registration of the fundus infrared reflectance image. Horizontal scans
(high resolution mode, 9mm, ART, average of a minimum of 50
images) through the fovea provided a view of the EZ-line and was
measured manually using Spectralis software. IR fundus imaging was
obtained with the Spectralis scanning laser confocal ophthalmoscope
(Heidelberg Engineering). IR imaging was obtained at 790 nm absorp-
tion and 830 nm emission using a 55° lens.
4.5. Sod3-/- mice
Sod3 knockout mice were generously provided by the Dr. Tim D.
Oury laboratory (Department of Pathology, University of Pittsburgh
Medical Center, Pittsburgh, PA). Sod3-/- mice were back-crossed into
the C57BL/6 genetic background and C57BL/6J mice (the Jackson
Laboratory, Bar Harbor, ME) were purchased and used as controls.
4.6. Mouse vitreous biopsies
The vitreous from 8 mouse eyes were eviscerated as described
previously [19,41]. Briefly, scleral tissue posterior to the limbus was
grasped with a 0.22 forcep and a microsurgical blade was used to make
a linear incision in the cornea from limbus to limbus. A fine curved
needle holder was inserted behind the lens and then pulled forward,
eviscerating both the lens and the vitreous. The lens-vitreous tissue was
centrifuged with 20 µL of protease inhibitor cocktail (Roche) dissolved
in PBS. The fine curved needle holder was placed as far posterior to the
globe as possible and the retina was eviscerated through the corneal
incision. Some vitreous also came with the retina. The retina-vitreous
tissue was also filtered. The filtered centrifuge tube was spun at
14,000 g for 12min and the eluent (vitreous) was collected.
4.7. Protein analysis
Total protein was measured using a NanoDrop 2000 spectro-
photometer (NanoDrop, Wilmington, DE). Protein quantity was de-
termined via absorbance at 280 nm [42].
4.8. Nitrate measurement
Levels of NO were measured in the gas phase using a Sievers NOA
280i chemiluminescence analyzer (Sievers NOA, Boulder, CO). Samples
were injected into a nitrogen purge vessel containing a 1% solution of
sodium iodide in glacial acetic acid to liberate gaseous NO from dis-
solved NO and nitrite. The sample gas was then exposed to ozone in the
reaction vessel to form activated nitrogen dioxide (NO2*), which was
detected by a red-sensitive photomultiplier tube and the output re-
corded using an integrating pen recorder. For each sample, the area
under the curve was converted to pmol NO using a calibration curve
constructed following the analysis of a series of sodium nitrite stan-
dards.
4.9. 3-Nitrotyrosine immunohistochemistry
Oxidative damage was localized in paraffin sections of mouse ocular
tissues by staining with an anti-nitrotyrosine antibody (StressMarq
Biosciences Inc.; Victoria, British Columbia, Canada) as previously de-
scribed [43].
4.10. SOD activity assay
Human post mortem vitreous base was dissected to obtain 50mg
pieces. The samples were incubated either with 250 μL of 50mM D-
glucose (n= 10) or phosphate buffer alone (n=5) at room tempera-
ture for 45min. Following incubation, samples were spun at 1000 g for
5min. The supernatant was collected, being careful to avoid the vitr-
eous base matrix at the bottom of the tube and applied to the
Superoxide Dismutase Activity Colorimetric Assay Kit (Abcam product
#ab65354). Activity is indicative of SOD3 released from the vitreous
base into the supernatant solution. Xanthine Oxidase was measured
using the Xanthine Oxidase Activity Assay Kit (Abcam; ab102522).
4.11. Dot blot array
We created a protein array of potential SOD3 binding partners by
dot blotting specific proteins (200 ng) in quadruplicate onto ni-
trocellulose membranes (BioRad, #162-0112) as previously described
[44]. Selected proteins include new vitreous collagens identified in our
vitreous proteome library, as well as previously known vitreous col-
lagens [45,46]. Following crosslinking of the proteins, blots were in-
cubated with 1 μg/mL of a human GST-SOD3 fusion protein (Protein
Tech, #ag5556), and then an HRP conjugated anti-GST antibody at
1:1000 (GE Healthcare, #RPN1236). Protein-protein interactions were
visualized and compared simultaneously with chemiluminescence de-
tection [47]. Recombinant SOD3 missing the heparin-binding domain
(ECSODΔHBD) or mutated with R213G were expressed in MIA PaCa-2
cells by a replication defective adenoviral vector; available through the
UI Radiation and Free Radical Research Core [44,48]. Mutant fusion
proteins were incubated with protein array blots, and interactions were
detected with an HRP conjugated anti-GST antibody as described
above.
4.12. Human immunohistochemistry
Human donor tissue was collected from postmortem eyes. Tissue
was embedded in optimal cutting temperature (OCT) medium and
frozen. Sections of ciliary body (including vitreous base) and sections of
macular retina and choroid (some including posterior hyaloid) were
collected at a thickness of 7 µm using a Microm cryostat equipped with
Cryo Jane adhesive tape onto Superfrost Plus slides (Fisher). Sections
were blocked with 0.1% bovine serum albumin in PBS for 15min.
Following the block, sections were incubated with rabbit anti-human
collagen IV and rabbit anti-human SOD3 (Abcam) antibodies diluted in
PBS for 1 h. Antibody incubation was followed by 3× 5min rinses in
PBS. Sections were incubated with goat anti-rabbit AlexaFluor 488,
AlexaFluor 594 and DAPI (Invitrogen, Eugene, OR).
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4.13. Intra-Ocular Pressure Recordings
Mice were anesthetized with an IP injection of 100mg/kg ketamine
hydrochloride and 5mg/kg xylazine. Using sterile probes, a tonometer
designed for the mouse eye was pressed against the cornea and used to
record a series of 5 measurements over approximately 10 s.
4.14. Pattern Electroretinogram (PERG)
Pattern-evoked electroretinography (PERG) was used to objectively
measure the function of RGCs by recording the amplitude of the PERG
waveform following TBI. Mice were anesthetized with a combination of
ketamine (0.03 mg/g, IP) and xylazine (0.005mg/g, IP), and then
placed on a heated recording table to maintain body temperature.
Neutral position PERG responses were evoked using alternating, re-
versing, and black and white vertical stimuli delivered on a monitor
(Jorvec, Miami, FL) and recorded using a nose electrode. A reference
needle electrode was placed at the base of the head, and a ground
electrode was placed at the base of the tail to complete the circuit. Each
animal was placed at the same fixed position in front of the monitor to
prevent recording variability due to animal placement. Stimuli (188
radius visual angle subtended on full field pattern, 2 reversals per
second, 372 averaged signals with cut off filter frequencies of 1–30 Hz,
98% contrast, 80 cd/m2 average monitor illumination intensity) were
delivered under mesopic conditions without dark adaptation to exclude
the possible effect of direct photoreceptor-derived evoked responses. A
diffuser placed over the pattern on the monitor also did not elicit a
measurable evoked potential, further ensuring that the electrical re-
sponses were elicited from the RGCs. The PERG response was evaluated
by measuring the amplitude (peak to trough) of the waveform. Human
PERG data was recorded according to ISCEV standards. The black trace
represents the mean response of 15 visually-normal subjects, and the
red trace is from a type 2 diabetic patient (59 years old, 20/25 VA,
moderate-severe NPDR, no history of treatment). Rescue experiments
were performed as described previously [49]. Briefly, Tempol (Sigma-
Aldrich Co.) was dissolved in ethanol vehicle and administered at
25 nM in the drinking water. Sucrose (4 g/100 mL) was supplemented
in the water bottles to offset the taste of the antioxidant. Mice were
treated at weaning (post-natal day 21) until the end of the experiment.
4.15. Statistical analyses
Differences in experimental groups were determined by the
Student's t-test as appropriate, or by one-way ANOVA followed by
Tukey's post-hoc multiple comparison's test. p values< 0.05 were
considered significant.
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